Sarepta therapeutics appoints stephen l. mayo, ph.d.

Cambridge, mass., nov. 17, 2021 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today announced the appointment of stephen l. mayo, ph.d., to its board of directors, effective immediately. dr. mayo is currently the bren professor of biology and chemistry at california institute of technology (caltech), and serves on the board of directors for merck and on the scientific advisory board of rubryc therapeutics.
SRPT Ratings Summary
SRPT Quant Ranking